10.25673/120600">
Proceedings of International Conference on Applied Innovation in IT  ·  2025/06/27  ·  Vol. 13  ·  Issue 2  ·  pp. 737–744
Molecular Detection of the Relationship between Biofilm Production and Antibiotic Resistance in Staphylococcus Haemolyticus
Yaser Radwan Mohammedali and Suha Maher Abed
📄 Download PDF DOI: <a href="http://dx.doi.org/10.25673/120600">10.25673/120600</a>
Abstract
To evaluate antibiotic resistance, biofilm formation, and the detection of virulence-associated genes this study was conduct. Clinical specimens samples were obtained from patients in Mosul city. susceptibility of Antibiotic was assessed using the Kirby-Bauer method with nineteen antibiotics. Biofilm production was tested using the tube adherence and microtiter plate methods. PCR was used to identifying virulence and resistance-related genes. Results showed a 94.7% resistance to ampicillin/cloxacillin and ceftriaxone, and 100% sensitivity to vancomycin and nitrofurantoin, with variability in resistance to other antibiotics. Biofilm formation was observed in all isolates. The PCR results showed that the SH gene was present in all isolates. The mecA gene, linked to methicillin resistance, was found in 88.88% of isolates, the tetK gene (tetracycline resistance) in 83.33%, and the ermC gene (erythromycin resistance) in 26.31%. Virulence factor genes, hla and fnbB, were detected in 100% and 73.68% of isolates, respectively. The findings highlight the significant antibiotic resistance, biofilm-forming ability, and horizontal gene transfer in Staphylococcus haemolyticus, emphasizing the global concern of multidrug-resistant bacteria.
Keywords
Antibiotic Resistance Biofilm Staphylococcus Haemolyticus Virulence Factors.
References
  1. P. Nikolic and P. Mudgil, "The cell wall, cell membrane and virulence factors of Staphylococcus aureus and their role in antibiotic resistance," Microorganisms, vol. 11, no. 2, p. 259, 2023.
  2. R. Michels, K. Last, S. L. Becker, and C. Papan, "Update on coagulase-negative staphylococci - what the clinician should know," Microorganisms, vol. 9, no. 4, p. 830, 2021.
  3. X. Argemi, Y. Hansmann, K. Prola, and G. Prévost, "Coagulase-negative staphylococci pathogenomics," Int. J. Mol. Sci., vol. 20, no. 5, p. 1215, 2019.
  4. C. C. Rossi, F. Ahmad, and M. Giambiagi-deMarval, "Staphylococcus haemolyticus: an updated review on nosocomial infections, antimicrobial resistance, virulence, genetic traits, and strategies for combating this emerging opportunistic pathogen," Microbiol. Res., p. 127652, 2024.
  5. L. C. Lin, T. P. Liu, S. C. Chang, and J. J. Lu, "Characterization of new Staphylococcus haemolyticus ST42 populations in Northern Taiwan," Microb. Drug Resist., vol. 28, no. 1, pp. 56-62, 2022.
  6. H. O. Eltwisy, H. O. Twisy, M. H. Hafez, I. M. Sayed, and M. A. El-Mokhtar, "Clinical infections, antibiotic resistance, and pathogenesis of Staphylococcus haemolyticus," Microorganisms, vol. 10, no. 6, p. 1130, 2022.
  7. F. H. Azharollah, A. Ahmadunissah, M. F. Abdullah, S. F. Nawi, and A. Abdul-Aziz, "Multidrug resistance profile and SCCmec typing of Staphylococcus haemolyticus in commensal and clinical isolates," J. Appl. Pharm. Sci., vol. 13, no. 3, pp. 158-167, 2023.
  8. M. Kornienko, E. Ilina, L. Lubasovskaya, T. Priputnevich, O. Falova, G. Sukhikh, et al., "Analysis of nosocomial Staphylococcus haemolyticus by MLST and MALDI-TOF mass spectrometry," Infect. Genet. Evol., vol. 39, pp. 99-105, 2016.
  9. H. S. Sader, D. J. Farrell, R. K. Flamm, J. M. Streit, R. E. Mendes, and R. N. Jones, "Antimicrobial activity of ceftaroline and comparator agents when tested against numerous species of coagulase-negative Staphylococcus causing infection in US hospitals," Diagn. Microbiol. Infect. Dis., vol. 85, no. 1, pp. 80-84, 2016.
  10. A. Ahmed, L. Satti, G. Zaman, A. Gardezi, N. Sabir, and M. T. Khadim, "Catheter-related recurrent bloodstream infection caused by linezolid-resistant, methicillin-resistant Staphylococcus haemolyticus; an emerging superbug," J. Pak. Med. Assoc., vol. 69, no. 1, pp. 123-126, 2019.
  11. O. Bouchami, M. Machado, J. A. Carriço, J. Melo-Cristino, H. de Lencastre, and M. Miragaia, "Spontaneous genomic variation as a survival strategy of nosocomial Staphylococcus haemolyticus," Microbiol. Spectr., vol. 11, no. 2, p. e02552-22, 2023.
  12. H. O. Eltwisy, M. Abdel-Fattah, A. M. Elsisi, M. M. Omar, A. A. Abdelmoteleb, and M. A. El-Mokhtar, "Pathogenesis of Staphylococcus haemolyticus on primary human skin fibroblast cells," Virulence, vol. 11, no. 1, pp. 1142-1157, 2020.
  13. R. Seng, T. Kitti, R. Thummeepak, P. Kongthai, U. Leungtongkam, S. Wannalerdsakun, et al., "Biofilm formation of methicillin-resistant coagulase-negative staphylococci (MR-CoNS) isolated from community and hospital environments," PLoS One, vol. 12, no. 8, p. e0184172, 2017.
  14. F. Hosseinkhani, F. Jabalameli, N. N. Farahani, M. Taherikalani, W. B. van Leeuwen, and M. Emaneini, "Variable number of tandem repeat profiles and antimicrobial resistance patterns of Staphylococcus haemolyticus strains isolated from blood cultures in children," Infect. Genet. Evol., vol. 38, pp. 19-21, 2016.
  15. W. Dong, Q. Peng, X. Tang, T. Zhong, S. Lin, Z. Zhi, et al., "Identification and characterization of a vancomycin intermediate-resistant Staphylococcus haemolyticus isolated from Guangzhou, China," Infect. Drug Resist., vol. 16, pp. 3639-3647, 2023.
  16. T. Czekaj, M. Ciszewski, and E. M. Szewczyk, "Staphylococcus haemolyticus - an emerging threat in the twilight of the antibiotics age," Microbiology, vol. 161, pt. 11, pp. 2061-2068, 2015.
  17. B. S. Nagoba and A. Pichare, Medical Microbiology and Parasitology PMFU, 4th ed., Elsevier Health Sciences, 2020.
  18. P. K. Glaeser, "Prokaryote characterization and identification," in Prokaryotic Biology and Symbiotic Associations, 2013, p. 10123.
  19. Y. D. Bakthavatchalam, Y. Manoharan, A. Shankar, K. Gunasekaran, K. Walia, and B. Veeraraghavan, "Understanding the rationale and clinical impact of the revised CLSI 2024 minocycline susceptibility breakpoints against Stenotrophomonas maltophilia," Eur. J. Clin. Microbiol. Infect. Dis., vol. 43, no. 1, pp. 1-5, 2024.
  20. S. Manandhar, A. Singh, A. Varma, S. Pandey, and N. Shrivastava, "Phenotypic and genotypic characterization of biofilm-producing clinical coagulase-negative staphylococci from Nepal and their antibiotic susceptibility pattern," Ann. Clin. Microbiol. Antimicrob., vol. 20, p. 1, 2021.
  21. J. Allkja, F. van Charante, J. Aizawa, I. Reigada, C. Guarch-Pérez, J. A. Vazquez-Rodriguez, et al., "Interlaboratory study for the evaluation of three microtiter plate-based biofilm quantification methods," Sci. Rep., vol. 11, no. 1, p. 13779, 2021.
  22. R. Omran and I. Al-Fatlawi, "Inexpensive and reliable rapid manual procedure for extracting genomic DNA from frozen blood samples," Pak. J. Biotechnol., vol. 14, no. 4, pp. 683-687, 2017.
  23. C. Pandozi, A. Matteucci, C. Pignalberi, L. Sgarra, M. Bonanni, M. V. Mariani, et al., "Antibiotic prophylaxis and treatment for cardiac device infections," Antibiotics, vol. 13, no. 10, p. 991, 2024.
  24. J. Zhuo, B. Liang, H. Zhang, Y. Chi, and Y. Cai, "An overview of gram-negative bacteria with difficult-to-treat resistance: definition, prevalence, and treatment options," Expert Rev. Anti Infect. Ther., vol. 21, no. 11, pp. 1203-1212, 2023.
  25. B. H. Nguyen-Thi, N. N. Pham-Thi, H. Y. Nguyen-Thi, L. N. Nguyen, and T. S. Le, "Unraveling the genetic basis of antibiotic resistance in Staphylococcus aureus: Focus on mecA and PVL genes," F1000Res., vol. 13, p. 802, 2024.
  26. M. Gopikrishnan and S. Haryini, "Emerging strategies and therapeutic innovations for combating drug resistance in Staphylococcus aureus strains: A comprehensive review," J. Basic Microbiol., vol. 64, no. 5, p. 2300579, 2024.
  27. Z. Taj and I. Chattopadhyay, "Staphylococcus aureus virulence factors and biofilm components: Synthesis, structure, function, and inhibitors," in ESKAPE Pathogens: Detection, Mechanisms, and Treatment Strategies, Springer Nature Singapore, 2024, pp. 227-270.
  28. Y. Z. Alabdaly, "Effect of diclofenac on the pharmacokinetics of ciprofloxacin in quail," Iraqi J. Vet. Sci., vol. 35, no. 4, pp. 777-781, 2021.
  29. F. H. Azharollah, A. Ahmadunissah, M. F. Abdullah, S. F. Nawi, and A. Abdul-Aziz, "Multidrug resistance profile and SCCmec typing of Staphylococcus haemolyticus in commensal and clinical isolates," J. Appl. Pharm. Sci., vol. 13, no. 3, pp. 158-167, 2023.
  30. M. H. Altememy and M. G. Saeed, "Prevalence and pathological study of trichomoniasis in the racing pigeons in Mosul city, Iraq," Iraqi J. Vet. Sci., vol. 37, no. 5, 2023.
  31. A. Gupta and B. Sharma, "Nitrofurantoin susceptibility profile versus other antibiotics tested in uropathogens—a retrospective study from India," Microbes Infect. Chemother., vol. 4, p. e2084, 2024.
  32. Z. W. Aziz, M. G. Saeed, and K. T. Tawfeeq, "Formalin versus Bouin solution for rat testicular tissue fixation: A histochemical and immunohistochemical evaluation," Int. J. Med. Toxicol. Forensic Med., vol. 13, no. 2, p. 40267-40267, 2023.
  33. S. A. Senobar Tahaei, A. Stájer, I. Barrak, E. Ostorházi, D. Szabó, and M. Gajdács, "Correlation between biofilm formation and the antibiotic-resistant phenotype in Staphylococcus aureus isolates: A laboratory-based study in Hungary and a review of the literature," Infect. Drug Resist., vol. 14, pp. 1155-1168, 2021.
  34. Z. Al-Taee and M. G. Saeed, "Molecular diagnosis of Adeno virus associated with hydropericardium hepatitis syndrome of the broiler chickens in Nineveh Province, Iraq," Egypt J. Vet. Sci., vol. 53, no. 4, pp. 583-589, 2022.
  35. D. Ochońska, Ł. Ścibik, and M. Brzychczy-Włoch, "Biofilm formation of clinical Klebsiella pneumoniae strains isolated from tracheostomy tubes and their association with antimicrobial resistance, virulence, and genetic diversity," Pathogens, vol. 10, no. 10, p. 1345, 2021.
  36. M. G. Saeed, "Investigation of urinary bladder lesions of slaughtered local bovine calves in Mosul city," Iraqi J. Vet. Sci., vol. 34, no. 1, pp. 45-51, 2020.
  37. M. A. Juma, T. Sonda, B. Wadugu, D. Kuchaka, M. Shayo, P. Paulo, et al., "Genomic detection of Panton-Valentine leucocidins encoding genes, virulence factors, and distribution of antiseptic resistance determinants among methicillin-resistant S. aureus isolates from patients attending regional referral hospitals in Tanzania," BMC Med. Genomics, vol. 18, no. 1, p. 14, 2025.
  38. O. M. Abdulrazaq and Y. Z. Alabdaly, "Effect of alkaline drinking water on vitamin D3 toxicity in female rats," 2023.
  39. C. C. Rossi, F. Ahmad, and M. Giambiagi-deMarval, "Staphylococcus haemolyticus: An updated review on nosocomial infections, antimicrobial resistance, virulence, genetic traits, and strategies for combating this emerging opportunistic pathogen," Microbiol. Res., p. 127652, 2024.
  40. Y. Z. Al-Abdaly, "Neurobehavioral evaluation of quail treated with omega-3 and chlorpyrifos," Iraqi J. Vet. Sci., vol. 37, suppl. I-IV, 2023.
  41. R. Aniba, A. Dihmane, H. Raqraq, A. Ressmi, K. Nayme, M. Timinouni, et al., "Molecular and phenotypic characterization of biofilm formation and antimicrobial resistance patterns of uropathogenic Staphylococcus haemolyticus isolates in Casablanca, Morocco," Diagn. Microbiol. Infect. Dis., vol. 110, no. 4, p. 116483, 2024.
  42. S. I. Alnuimi and Y. Z. Alabdaly, "Role of coenzyme Q-10 in copper sulphate toxicity in chick's model," Egypt J. Vet. Sci., vol. 53, no. 3, pp. 431-441, 2022.
  43. B. Wang, C. R. Song, Q. Y. Zhang, P. W. Wei, X. Wang, Y. H. Long, et al., "The fusaric acid derivative QY17 inhibits Staphylococcus haemolyticus by disrupting biofilm formation and the stress response via altered gene expression," Front. Microbiol., vol. 13, p. 822148, 2022.
  44. M. Alfathi, Y. Alabdaly, and F. Al-Hayyali, "Ameliorative effect of spirulina against gentamicin toxicity in liver and kidney tissues of male rat," Egypt. J. Histol., vol. 46, no. 4, pp. 1666-1675, 2023.

Proceedings of the International Conference on Applied Innovations in IT by Anhalt University of Applied Sciences is licensed under CC BY-SA 4.0  ·  This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License

ICAIIT 2026
International Conference on Applied Innovation in IT
Navigation
Publisher
ISSN2199-8876
Publisher Edition Hochschule Anhalt
Location Anhalt University of Applied Sciences
Email leiterin.hsb@hs-anhalt.de
Phone +49 (0) 3496 67 5611
Address Building 01, Room 425
Bernburger Str. 55
D-06366 Köthen, Germany
Open Access License
CC BY-SA 4.0

All works are licensed under the Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0), unless otherwise noted.

Published by ICAIIT in cooperation with Anhalt University of Applied Sciences.

© 2026 ICAIIT — International Conference on Applied Innovations in IT. Anhalt University of Applied Sciences, Köthen, Germany.
Visitors: site traffic counter